BSc, PhD, MSc, LLM, FIBiol, FRCPath.
Strategic & Preclinical Advisor
David has more than 20 years experience in large pharmaceutical companies, having held senior global positions in R&D within GlaxoWellcome. He moved into the biotechnology sector in 2000 working as R&D director for Strakan Ltd (now ProStrakan Group), Charterhouse Therapeutics Ltd and Antisoma plc before undertaking several CEO positions.
He was a non-executive director of BIBRA International, Enhance Biotech Inc, and was a board member at the UK Public Health Laboratory Service. He has 3 degrees from London University and the Royal Postgraduate Medical School. He was awarded a Fellowship of the Royal College of Pathologists in 1993 and an LLM from the Cardiff Law School in 1995. He held visiting chairs at King’s College and the School of Pharmacy at London University.